Cargando…
Expression of AIB1 protein as a prognostic factor in breast cancer
BACKGROUND: AIB1 (amplified in breast cancer I) is a member of the p160 steroid receptor coactivator family. AIB1 is frequently overexpressed in breast cancer and has functions that promote oncogenesis that are independent of estrogen receptor (ER) coactivation. We investigated prognostic significan...
Autores principales: | Lee, Kyungji, Lee, Ahwon, Song, Byung Joo, Kang, Chang Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235064/ https://www.ncbi.nlm.nih.gov/pubmed/22035181 http://dx.doi.org/10.1186/1477-7819-9-139 |
Ejemplares similares
-
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
por: Eom, Yong Hwa, et al.
Publicado: (2016) -
Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
por: Kim, Tae-Jung, et al.
Publicado: (2012) -
Expression of pRb, p53, p16 and Cyclin D1 and Their Clinical Implications in Urothelial Carcinoma
por: Lee, Kyungji, et al.
Publicado: (2010) -
Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis
por: Kiliti, Amber J., et al.
Publicado: (2023) -
Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy
por: Chae, Byung Joo, et al.
Publicado: (2009)